US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Regentis Biomaterials Ltd.

2.38

+0.16007.21%

Post-market: 2.29-0.0900-3.78%19:57 EDT

Volume:107.69K

Turnover:258.45K

Market Cap:16.75M

PE:-0.10

High:2.56

Open:2.22

Low:2.10

Close:2.22

52wk High:15.50

52wk Low:1.23

Shares:7.04M

Float Shares:4.84M

Volume Ratio:0.74

T/O Rate:2.22%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-24.1591

EPS(LYR):-24.1600

ROE:--

ROA:-107.53%

PB:3.53

PE(LYR):-0.10

Loading ...

Overview Company News Filings

Amex Halt News Pending Lst 3.870000

THOMSON REUTERS

Amex Halt Add Info Lst 2.560000

THOMSON REUTERS

Top Midday Gainers

MT Newswires Live

Amex Halt Add Info Lst 6.540000

THOMSON REUTERS

Top Premarket Gainers

MT Newswires Live

Regentis Biomaterials (NYSE American: RGNT) Advances European Commercial Launch Plans for GelrinC

Regentis Biomaterials to commence European surgeon training for GelrinC

Regentis Biomaterials (NYSE American: RGNT) Advances Simplified Cartilage Repair Platform Toward Key Commercial Milestones

Regentis Biomaterials (NYSE American: RGNT) Targets Major Gap in Knee Cartilage Repair Market with Off-the-Shelf Regenerative Implant

Regentis Biomaterials Sets July 2, 2026 AGM to Vote on Director Incentives, Compensation Policy and Auditor

Regentis Biomaterials announces annual shareholder meeting

Regentis Biomaterials (NYSE American: RGNT) Is ‘One to Watch’

Regentis Biomaterials (NYSE American: RGNT) and the Off-the-Shelf Opportunity in Knee Cartilage Repair

NYSE American New 52-Week Highs And Lows

Amex Halt Add Info Lst 2.730000

THOMSON REUTERS

Regentis Biomaterials enters collaboration with Humanitas Research Hospital

Regentis Biomaterials files Form 3 for Chief Medical Officer Galit Reske

Regentis Biomaterials Director Keith Valentine Files Initial Beneficial Ownership Statement

Regentis Biomaterials Ltd. CEO Ehud Geller files initial beneficial ownership statement

Regentis Biomaterials Director Susan Alpert filed initial beneficial ownership statement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RGNT/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RGNT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RGNT\",,,,,undefined,":{"symbol":"RGNT","market":"US","secType":"STK","nameCN":"Regentis Biomaterials Ltd.","latestPrice":2.38,"timestamp":1784318400000,"preClose":2.22,"halted":0,"volume":107694,"hourTrading":{"tag":"盘后","latestPrice":2.29,"preClose":2.38,"latestTime":"19:57 EDT","volume":3014,"amount":6925.3718,"timestamp":1784332637750,"change":-0.09,"changeRate":-0.037815,"amplitude":0.042017},"delay":0,"changeRate":0.07207207207207193,"floatShares":4842164,"shares":7036500,"eps":-24.159056,"marketStatus":"Market Closed","change":0.16,"latestTime":"07-17 16:00:00 EDT","open":2.22,"high":2.56,"low":2.1,"amount":258446.915091,"amplitude":0.207207,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-24.159056,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1784534400000},"marketStatusCode":7,"adr":0,"listingDate":1764824400000,"exchange":"AMEX","adjPreClose":2.22,"preHourTrading":{"tag":"盘前","latestPrice":2.2482,"preClose":2.22,"latestTime":"09:14 EDT","volume":1831,"amount":4201.9426745,"timestamp":1784294094017,"change":0.0282,"changeRate":0.012703,"amplitude":0.18018},"postHourTrading":{"tag":"盘后","latestPrice":2.29,"preClose":2.38,"latestTime":"19:57 EDT","volume":3014,"amount":6925.3718,"timestamp":1784332637750,"change":-0.09,"changeRate":-0.037815,"amplitude":0.042017},"volumeRatio":0.7410837904356272},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RGNT\",,,,,undefined,":{"symbol":"RGNT","floatShares":4842164,"roa":"-107.53%","roe":"--","lyrEps":-24.159999,"volumeRatio":0.7410837904356272,"shares":7036500,"dividePrice":0,"high":2.56,"amplitude":0.207207,"preClose":2.22,"low":2.1,"week52Low":1.2316,"pbRate":"3.53","week52High":15.5,"institutionHeld":0,"latestPrice":2.38,"eps":-24.159056,"divideRate":0,"volume":107694,"delay":0,"ttmEps":-24.159056,"open":2.22,"prevYearClose":6.74,"prevWeekClose":3.79,"prevMonthClose":3.53,"prevQuarterClose":3.53,"fiveDayClose":3.79,"twentyDayClose":4.75,"sixtyDayClose":2.97},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RGNT\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RGNT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RGNT\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RGNT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RGNT","date":"2026-07-17","current":-0.098514,"percent":0.825301,"low":-9.624274,"twenty":-6.113394,"median":-1.339625,"eighty":-0.916106,"high":11.294138,"avg":-2.582306,"sd":3.728218,"marketCap":11498219},"quantilePoints":[{"date":"2025-09-12","current":11.294138,"twenty":11.294138,"median":11.294138,"eighty":11.294138,"marketCap":54223158},{"date":"2025-09-17","current":11.294138,"twenty":11.294138,"median":11.294138,"eighty":11.294138,"marketCap":54223158},{"date":"2025-11-14","current":-9.624274,"twenty":-1.256909,"median":11.294138,"eighty":11.294138,"marketCap":54223158},{"date":"2025-11-20","current":-9.624274,"twenty":-9.624274,"median":11.294138,"eighty":11.294138,"marketCap":54223158},{"date":"2025-11-26","current":-9.624274,"twenty":-9.624274,"median":-9.624274,"eighty":11.294138,"marketCap":54223158},{"date":"2025-12-05","current":-6.894806,"twenty":-9.624274,"median":-7.354459,"eighty":11.294138,"marketCap":38845335},{"date":"2025-12-12","current":-6.563855,"twenty":-9.624274,"median":-6.89021,"eighty":11.294138,"marketCap":36980758},{"date":"2025-12-19","current":-5.880074,"twenty":-9.624274,"median":-6.600627,"eighty":11.294138,"marketCap":33128337},{"date":"2025-12-26","current":-6.113394,"twenty":-9.624274,"median":-6.527083,"eighty":1.180569,"marketCap":34442863},{"date":"2026-01-02","current":-6.196132,"twenty":-8.716348,"median":-6.3708,"eighty":-5.580196,"marketCap":34909007},{"date":"2026-01-09","current":-6.352414,"twenty":-7.170598,"median":-6.31555,"eighty":-5.626198,"marketCap":35789501},{"date":"2026-01-16","current":-7.078667,"twenty":-7.005123,"median":-6.260483,"eighty":-5.72734,"marketCap":39881210},{"date":"2026-01-23","current":-6.664979,"twenty":-6.894806,"median":-6.333844,"eighty":-5.846096,"marketCap":37550490},{"date":"2026-01-30","current":-5.635354,"twenty":-6.892967,"median":-6.278869,"eighty":-5.846096,"marketCap":31749587},{"date":"2026-02-06","current":-4.421869,"twenty":-6.856195,"median":-6.196132,"eighty":-5.571003,"marketCap":24912808},{"date":"2026-02-13","current":-4.026566,"twenty":-6.723814,"median":-6.113762,"eighty":-5.331983,"marketCap":22685675},{"date":"2026-02-20","current":-3.594492,"twenty":-6.664979,"median":-6.113394,"eighty":-4.421869,"marketCap":20251367},{"date":"2026-02-27","current":-1.495219,"twenty":-6.600627,"median":-6.113394,"eighty":-4.026566,"marketCap":20406749},{"date":"2026-03-06","current":-1.271316,"twenty":-6.563855,"median":-6.053639,"eighty":-3.612878,"marketCap":17350916},{"date":"2026-03-13","current":-1.282663,"twenty":-6.527083,"median":-5.880074,"eighty":-1.504175,"marketCap":17505779},{"date":"2026-03-20","current":-1.196479,"twenty":-6.527083,"median":-5.644593,"eighty":-1.282663,"marketCap":16329542},{"date":"2026-03-27","current":-1.153672,"twenty":-6.526991,"median":-5.56181,"eighty":-1.271316,"marketCap":15745309},{"date":"2026-04-02","current":-1.138492,"twenty":-6.505001,"median":-5.341176,"eighty":-1.230216,"marketCap":15538134},{"date":"2026-04-10","current":-1.159364,"twenty":-6.396541,"median":-4.971155,"eighty":-1.194415,"marketCap":15822999},{"date":"2026-04-17","current":-1.214391,"twenty":-6.356091,"median":-4.421869,"eighty":-1.179477,"marketCap":16574009},{"date":"2026-04-24","current":-1.168851,"twenty":-6.34506,"median":-4.136653,"eighty":-1.176433,"marketCap":15952484},{"date":"2026-05-01","current":-1.104337,"twenty":-6.335719,"median":-3.755371,"eighty":-1.159364,"marketCap":15071989},{"date":"2026-05-08","current":-0.865254,"twenty":-6.326637,"median":-3.645054,"eighty":-1.156707,"marketCap":11808981},{"date":"2026-05-15","current":-0.777969,"twenty":-6.302772,"median":-3.401437,"eighty":-1.138492,"marketCap":10617724},{"date":"2026-05-22","current":-0.815919,"twenty":-6.267838,"median":-1.499697,"eighty":-1.134697,"marketCap":11135662},{"date":"2026-05-29","current":-0.751404,"twenty":-6.243936,"median":-1.282663,"eighty":-1.110409,"marketCap":10255168},{"date":"2026-06-05","current":-0.652735,"twenty":-6.210841,"median":-1.277843,"eighty":-0.952538,"marketCap":8908530},{"date":"2026-06-12","current":-0.721045,"twenty":-6.196132,"median":-1.273213,"eighty":-0.865254,"marketCap":9840818},{"date":"2026-06-18","current":-1.802612,"twenty":-6.163331,"median":-1.275111,"eighty":-0.865254,"marketCap":24602045},{"date":"2026-06-26","current":-1.574913,"twenty":-6.113836,"median":-1.282663,"eighty":-0.878916,"marketCap":21494418},{"date":"2026-07-02","current":-1.734302,"twenty":-6.113394,"median":-1.282663,"eighty":-0.902444,"marketCap":23669757},{"date":"2026-07-10","current":-1.38137,"twenty":-6.113394,"median":-1.369985,"eighty":-0.917624,"marketCap":18852935},{"date":"2026-07-17","current":-0.842484,"twenty":-6.113394,"median":-1.339625,"eighty":-0.916106,"marketCap":11498219}],"updateTime":1784425146319},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RGNT\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2643371202","title":"Amex Halt  News Pending Lst 3.870000","url":"https://stock-news.laohu8.com/highlight/detail?id=2643371202","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643371202?lang=en_us&edition=fundamental","pubTime":"2026-06-15 23:41","pubTimestamp":1781538072,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nAQN2M3KAF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RGNT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643209693","title":"Amex Halt  Add Info Lst 2.560000","url":"https://stock-news.laohu8.com/highlight/detail?id=2643209693","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643209693?lang=en_us&edition=fundamental","pubTime":"2026-06-15 21:42","pubTimestamp":1781530968,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nAQN2M3KAI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RGNT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642494806","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2642494806","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642494806?lang=en_us&edition=fundamental","pubTime":"2026-06-10 02:12","pubTimestamp":1781028762,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials  said Monday it plans to begin European surgeon training activities in Q3 ahead of the commercial rollout of its GelrinC in knee cartilage repair.Shares soared over 130%, with more than 97.7 million shares traded intraday, compared with a daily average of about 27,000.J.M. Smucker  reported better-than-expected fiscal Q4 results on Tuesday, while the food producer's full-year earnings outlook came in above Wall Street's estimates at the midpoint.Shares climbed 9.6% following a rise in intraday trading volume to over 3.3 million from a daily average of about 1.9 million.Oil-Dri of America  reported a jump in fiscal Q3 earnings and revenue late Monday.Shares jumped 14%, with intraday trading volume rising to more than 166,000 from a daily average of about 67,000.Price: 2.99, Change: +1.71, Percent Change: +133.59","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4018","BK4139","BK4588","BK4212","RGNT","ODC","BK4585","SJM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642932654","title":"Amex Halt  Add Info Lst 6.540000","url":"https://stock-news.laohu8.com/highlight/detail?id=2642932654","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642932654?lang=en_us&edition=fundamental","pubTime":"2026-06-09 22:09","pubTimestamp":1781014189,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nAQN2M2Q2B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RGNT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642346475","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2642346475","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642346475?lang=en_us&edition=fundamental","pubTime":"2026-06-09 19:12","pubTimestamp":1781003538,"startTime":"0","endTime":"0","summary":"Core AI  shares were up 458% in Tuesday premarket activity, reversing from a 1.3% loss in the previous session.CCSC Technology International  stock was 242% higher, adding to a 3.1% gain in the Monday session.Smart Logistics Global  shares were up 186%, adding to a 2.8% rise in the earlier session.Regentis Biomaterials  shares were up 174% after the company announced plans to begin European surgeon training activities in Q3 ahead of the commercial rollout of its GelrinC treatment for knee cartilage lesions.Global Mofy AI  stock was 154% higher after the company said its Mofy Clip unit co-invested in two AI-powered micro-drama series with Hongguo Short Drama and completed AI-powered production for both projects.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ARTY","BK4139","AIPO","BK4551","CCTG","BK4588","BK4587","AI","RGNT","BK4528","GMM","BK4148","SLGB","BK4232","AIYY","BK4108","BK4023","BK4585","CHAT","BK4543","CHAI","BK4020","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642435515","title":"Regentis Biomaterials (NYSE American: RGNT) Advances European Commercial Launch Plans for GelrinC","url":"https://stock-news.laohu8.com/highlight/detail?id=2642435515","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642435515?lang=en_us&edition=fundamental","pubTime":"2026-06-09 01:00","pubTimestamp":1780938009,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, June 8th, 2026, FinanceWire Regentis Biomaterials (NYSE American: RGNT) announced plans to begin European s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-advances-european-commercial-launch-plans-for-gelrinc?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-advances-european-commercial-launch-plans-for-gelrinc?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AFG","BK4107","BK4117","EPV","BK4139","RGNT","NYSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641904484","title":"Regentis Biomaterials to commence European surgeon training for GelrinC","url":"https://stock-news.laohu8.com/highlight/detail?id=2641904484","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641904484?lang=en_us&edition=fundamental","pubTime":"2026-06-08 20:41","pubTimestamp":1780922464,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials (RGNT) announced that in the third quarter of 2026, the Company plans to commence its European surgeon training activities, a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regentis-biomaterials-to-commence-european-surgeon-training-for-gelrinc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regentis-biomaterials-to-commence-european-surgeon-training-for-gelrinc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EPV","RGNT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640896565","title":"Regentis Biomaterials (NYSE American: RGNT) Advances Simplified Cartilage Repair Platform Toward Key Commercial Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2640896565","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640896565?lang=en_us&edition=fundamental","pubTime":"2026-06-02 00:30","pubTimestamp":1780331407,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, June 1st, 2026, FinanceWire Regentis Biomaterials Ltd. (NYSE American: RGNT) is advancing GelrinC®, a cell-free h...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-advances-simplified-cartilage-repair-platform-toward-key-commercial-milestones?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-advances-simplified-cartilage-repair-platform-toward-key-commercial-milestones?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4107","BK4117","NYSE","AFG","RGNT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639804671","title":"Regentis Biomaterials (NYSE American: RGNT) Targets Major Gap in Knee Cartilage Repair Market with Off-the-Shelf Regenerative Implant","url":"https://stock-news.laohu8.com/highlight/detail?id=2639804671","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639804671?lang=en_us&edition=fundamental","pubTime":"2026-05-30 01:00","pubTimestamp":1780074008,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, May 29th, 2026, FinanceWire Regentis Biomaterials Ltd. (NYSE American: RGNT) is advancing GelrinC(R), a cell-free hyd...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-targets-major-gap-in-knee-cartilage-repair-market-with-off-the-shelf-regenerative-implant?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-targets-major-gap-in-knee-cartilage-repair-market-with-off-the-shelf-regenerative-implant?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4022","BK4139","NYSE","RGNT","BK4107","BK4232","BK4117","R","AFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639117786","title":"Regentis Biomaterials Sets July 2, 2026 AGM to Vote on Director Incentives, Compensation Policy and Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2639117786","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639117786?lang=en_us&edition=fundamental","pubTime":"2026-05-29 05:45","pubTimestamp":1780004731,"startTime":"0","endTime":"0","summary":"The latest update is out from Regentis Biomaterials Ltd ( ($RGNT) ). On May 28, 2026, Regentis Biomaterials announced it will hold its Annual Gener...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regentis-biomaterials-sets-july-2-2026-agm-to-vote-on-director-incentives-compensation-policy-and-auditor?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regentis-biomaterials-sets-july-2-2026-agm-to-vote-on-director-incentives-compensation-policy-and-auditor?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","RGNT","BK4229","BK4195","AGM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639619163","title":"Regentis Biomaterials announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2639619163","media":"Reuters","labels":["conferences","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639619163?lang=en_us&edition=fundamental","pubTime":"2026-05-29 04:46","pubTimestamp":1780001218,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials will hold its annual general meeting in Tel Aviv, Israel on July 2, 2026.Shareholders will vote on the re-election of Class I directors Ehud Geller, Efraim Cohen-Arazi.Resolutions cover equity awards, including director option grants at a US$ 2.16 exercise price, a top-up option grant for Pini Ben-Elazar.Proposals also include issuing replacement warrants to certain lenders, including warrants for Ehud Geller, Jeff Dykan at an exercise price of NIS 0.01.Items include adopting a compensation policy, reappointing Deloitte Israel as independent auditor for the year ending Dec. 31, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regentis Biomaterials Ltd. published the original content used to generate this news ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL6PdMGQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGNT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639690892","title":"Regentis Biomaterials (NYSE American: RGNT) Is ‘One to Watch’","url":"https://stock-news.laohu8.com/highlight/detail?id=2639690892","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639690892?lang=en_us&edition=fundamental","pubTime":"2026-05-29 01:00","pubTimestamp":1779987614,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, May 28th, 2026, FinanceWire GelrinC(R) is positioned as a potential first-in-class, off-the-shelf solution for knee c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-is-one-to-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-is-one-to-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4232","AFG","RGNT","BK4117","BK4107","R","BK4022","NYSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638549139","title":"Regentis Biomaterials (NYSE American: RGNT) and the Off-the-Shelf Opportunity in Knee Cartilage Repair","url":"https://stock-news.laohu8.com/highlight/detail?id=2638549139","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638549139?lang=en_us&edition=fundamental","pubTime":"2026-05-27 00:30","pubTimestamp":1779813007,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, May 26th, 2026, FinanceWire Approximately 472,500 arthroscopic knee procedures in the U.S. each year involve cartilag...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-and-the-off-the-shelf-opportunity-in-knee-cartilage-repair?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-and-the-off-the-shelf-opportunity-in-knee-cartilage-repair?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NYSE","BK4139","BK4107","AFG","RGNT","BK4117"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632895949","title":"NYSE American New 52-Week Highs And Lows","url":"https://stock-news.laohu8.com/highlight/detail?id=2632895949","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632895949?lang=en_us&edition=fundamental","pubTime":"2026-05-04 22:21","pubTimestamp":1777904460,"startTime":"0","endTime":"0","summary":"COMPANY                      SYMBOL       HIGH         VOLUME. -------                      ------       ----         ------. abrdn EM ex-China Fd         AEF          9.31         20,598. Bancroft Fund                BCV         24.68          3,700. Ellsworth Growth & Incm      ECF         12.75         13,847. OptimumBank Holdings         OPHC         5.60          5,488. COMPANY                      SYMBOL       LOW          VOLUME. -------                      ------       ----         ------. CEL-SCI                      CVM          1.72        401,173. Regentis Biomaterials        RGNT         2.40          7,385. Copyright (c) 2026 Dow Jones & Company, Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGNT","BK4139","BK4107","BK4117","AFG","NYSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629842971","title":"Amex Halt  Add Info Lst 2.730000","url":"https://stock-news.laohu8.com/highlight/detail?id=2629842971","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629842971?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:37","pubTimestamp":1777037838,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nAQN2LW0E5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RGNT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627215368","title":"Regentis Biomaterials enters collaboration with Humanitas Research Hospital","url":"https://stock-news.laohu8.com/highlight/detail?id=2627215368","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627215368?lang=en_us&edition=fundamental","pubTime":"2026-04-16 20:51","pubTimestamp":1776343882,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials (RGNT) announced a collaboration with Humanitas Research Hospital in Milan, Italy,. This collaboration is currently in the pr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regentis-biomaterials-enters-collaboration-with-humanitas-research-hospital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regentis-biomaterials-enters-collaboration-with-humanitas-research-hospital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RGNT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623324566","title":"Regentis Biomaterials files Form 3 for Chief Medical Officer Galit Reske","url":"https://stock-news.laohu8.com/highlight/detail?id=2623324566","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623324566?lang=en_us&edition=fundamental","pubTime":"2026-03-31 05:32","pubTimestamp":1774906347,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials Chief Medical Officer Galit Reske reported holding employee stock options for 67,961 shares at a $4 exercise price in an initial beneficial ownership filing dated March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regentis Biomaterials Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 30, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDLTbmpD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RGNT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620779262","title":"Regentis Biomaterials Director Keith Valentine Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620779262","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620779262?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:32","pubTimestamp":1773865930,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials reported an initial statement of beneficial ownership by director Keith Valentine. Keith Valentine disclosed an employee stock option for 37,500 shares of common stock. The option has an exercise price of USD 1.46 and an expiration date of Jan. 9, 2029.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regentis Biomaterials Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL9nb7C8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGNT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620262032","title":"Regentis Biomaterials Ltd. CEO Ehud Geller files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620262032","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620262032?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:32","pubTimestamp":1773865927,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials reported an initial statement of beneficial ownership by Ehud Geller, a director and chief executive officer. The filing reported employee stock options covering 182,000 shares with an exercise price of USD 0.01. It also reported employee stock options covering 283,533 shares with an exercise price of USD 0.01. The filing reported warrants to purchase 92,821 shares with an exercise price of USD 5.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regentis Biomaterials Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL6v6vCG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGNT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620262722","title":"Regentis Biomaterials Director Susan Alpert filed initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620262722","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620262722?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:32","pubTimestamp":1773865920,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials reported an initial statement of beneficial ownership filed by Susan Alpert. Susan Alpert is listed as a director. The filing stated that Susan Alpert beneficially owned no securities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regentis Biomaterials Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL5BWfJM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGNT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":61,"code":"91000000","status":"200"}]}}